whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death

June 2012

Please see the March 2013 FDA statement concerning the risk QT interval prolongation with Azithromycin

You'll hear new concerns about whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death.

Erythromycin and clarithromycin can prolong the QT interval and cause fatal arrhythmias (torsades).

Now azithromycin is also associated with a small risk...especially in patients with heart disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote